What is JFL Life Sciences Ltd (JFLLIFE) share price return in the past 10 years?

Data is not available for this company

What is the share price of JFL Life Sciences Ltd (JFLLIFE)?

Company share prices are keep on changing according to the market conditions. The current trading price of JFL Life Sciences Ltd (JFLLIFE) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of JFL Life Sciences?

The latest standalone P/E ratio of JFL Life Sciences as of 01-Jan-1970 is 6.43.

What is the P/B ratio of JFL Life Sciences Ltd (JFLLIFE)?

The latest standalone P/B ratio of JFL Life Sciences Ltd (JFLLIFE) as of 01-Jan-1970 is 0.70.

What is the 52-week high and low of JFL Life Sciences Ltd (JFLLIFE)?

The 52-week high of JFL Life Sciences Ltd (JFLLIFE) is Rs. 0.00 and the 52-week low is Rs. 0.00.

JFL Life Sciences Ltd (JFLLIFE) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: JFL Life Sciences Ltd (JFLLIFE)
Brand: JFL Life Sciences

JFL Life Sciences Ltd (JFLLIFE) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

JFL Life Sciences Ltd (JFLLIFE)

BSE: 0 NSE: JFLLIFE

Key Metrics

Market Cap

₹31 Cr.

P/E Ratio

6.43

Price to Book (P/B)

0.70

Price to Sales (P/S)

0.39

EV/EBITDA

4.17

Return on Capital Employed (ROCE)

15.81%

Current Price

₹0

Return on Equity (ROE)

11.09%

Return on Assets (ROA)

6.47%

Operating Profit Margin

10%

Net Profit Margin

5.07%

Gross Profit Margin

8.7%

Book Value per Share

₹13.4

Sales Growth (YoY)

76.24%

Sales Growth (3 Years)

34.67%

Operating Profit Growth (1 Year)

79.04%

Operating Profit Growth (3 Years)

15.23%

Net Profit Growth (1 Year)

26.06%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

13.96%

Dividend Yield

0.00%

Promoter Holding

67.47%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Stock return of JFL Life Sciences Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of -40.08% based on the current price.

Q.1 Revenue growth of JFL Life Sciences Ltd?

JFL Life Sciences Ltd revenue growth is 76.2% for FY-2025, which is above its 5-year CAGR of 22.15%, indicating faster growth.

Q.1 Which industry/sub-sector does JFL Life Sciences Ltd belong to?

JFL Life Sciences Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Promoter shareholding and pledge status of JFL Life Sciences Ltd?

Promoters hold 67.47% of the JFL Life Sciences Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of JFL Life Sciences Ltd vs industry peers?

JFL Life Sciences Ltd revenue CAGR is 22.15%, compared to the industry median CAGR of 8.30%, indicating faster growth and gaining its market share.

DeciZen - make an informed investing decision on JFL Life Sciences

Based on:

Data

M-Cap below 100cr DeciZen not available

JFL Life Sciences stock performance

Key Ratios

Is JFL Life Sciences Ltd an attractive stock to invest in?

1. Is JFL Life Sciences Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that JFL Life Sciences Ltd is a average quality company.

2. Is JFL Life Sciences Ltd undervalued or overvalued?

The key valuation ratios of JFL Life Sciences Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is JFL Life Sciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of JFL Life Sciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	8.7%	11.8%	10.3%	23.1%	15.5%	11.5%	15.8%	-
Value Creation Index ⓘ	-0.4	-0.2	-0.3	0.7	0.1	-0.2	0.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	31.8	30.2	32.8	33.6	42.8	46.6	82	80
Sales YoY Gr.	-	-5.1%	8.6%	2.5%	27.5%	8.7%	76.2%	-
Adj EPS ⓘ	0.2	0.2	0.3	1.2	0.9	1	1.3	1.5
YoY Gr.	-	22.2%	27.3%	314.3%	-26.7%	17.7%	26%	-
BVPS (₹) ⓘ	3	3.3	3.6	4.7	9.8	10.8	12	13.4
Adj Net Profit ⓘ	0.3	0.4	0.5	2.8	2.8	3.3	4.2	5
Cash Flow from Ops. ⓘ	-3	3.2	-5.9	2.3	-9.1	8.4	-3.5	-
Debt/CF from Ops. ⓘ	-2.8	2.9	-2.9	6.8	-0.8	0.7	-3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	22.2%	34.7%	76.2%
Adj EPS ⓘ	NA	41.8%	2.8%	26%
BVPSⓘ	NA	29.7%	36.6%	11%
Share Price	-	-	-40.1%	-49.9%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	6	6.9	8.8	30.6	12.9	9.7	11.1	11.5
Op. Profit Mgn % ⓘ	4.2	6.2	6.6	16	9.2	9.8	10	12
Net Profit Mgn % ⓘ	1	1.2	1.6	8.3	6.6	7.1	5.1	6
Debt to Equity ⓘ	1.7	1.7	2.5	1.4	0.2	0.2	0.3	-
Working Cap Days ⓘ	0	197	231	345	354	337	230	169
Cash Conv. Cycle ⓘ	0	103	108	172	182	213	148	77

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 11.50%

Sales growth is growing at healthy rate in last 3 years 34.67%

Net Profit has been subdued in last 3 years 2.79%

Sales growth is not so good in last 4 quarters at -5.61%

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	1.5	-
TTM Sales (₹ Cr.)	80.1	-
BVPS (₹) ⓘ	13.4	-
Reserves (₹ Cr.) ⓘ	11	-
P/BV ⓘ	0.70	-
PE ⓘ	6.43	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	31
Equity (₹ Cr.)	33
Face Value (₹)	10
Industry PE ⓘ	43.4

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of JFL Life Sciences - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	31.78	30.17	32.77	33.59	42.83	46.55	82.04
Operating Expenses ⓘ +	30.46	28.31	30.61	28.23	38.90	41.97	73.84
Manufacturing Costs	0.18	0.30	0.19	0.30	0.34	0.48	0.48
Material Costs	29.13	26.46	28.91	25.80	35.71	39.95	66.11
Employee Cost	0.96	1.25	0.98	1.43	1.83	0.91	1.01
Other Costs ⓘ	0.19	0.31	0.53	0.70	1.02	0.62	6.25
Operating Profit ⓘ	1.32	1.86	2.16	5.36	3.93	4.58	8.20
Operating Profit Margin (%)	4.2%	6.2%	6.6%	16.0%	9.2%	9.8%	10.0%
Other Income ⓘ +	0	0.03	0.09	0.89	1.64	0.51	0.01
Exceptional Items ⓘ	0	0	0	0	0	0	0
Interest ⓘ	0.75	1.16	1.23	2.08	1.42	0.86	1.08
Depreciation ⓘ	0.15	0.24	0.28	0.37	0.43	0.44	0.99
Profit Before Tax ⓘ	0.42	0.50	0.75	3.80	3.72	3.79	6.14
Tax ⓘ	0.12	0.14	0.20	0.99	0.91	0.49	1.98
Profit After Tax	0.30	0.36	0.54	2.81	2.81	3.30	4.16
PAT Margin (%)	1.0%	1.2%	1.7%	8.4%	6.6%	7.1%	5.1%
Adjusted EPS (₹)	0.2	0.2	0.3	1.2	0.9	1.0	1.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	8.30%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	5.01	5.38	6.87	11.29	32.27	35.58	39.46
Share Capital ⓘ	0.42	0.42	0.50	8.02	11	11	33
Reserves ⓘ	4.59	4.95	6.38	3.27	21.27	24.58	6.46
Debt +	6.93	7.64	13.60	13.79	7.18	5.11	10.16
Long Term Debt	2.90	1.31	8.18	8.41	1.39	0.40	0.38
Short Term Debt	4.04	6.33	5.42	5.38	5.79	4.71	9.78
Minority Interest	0	0	0	0	0	0	0
Trade Payables	1.42	8.82	4.57	15.44	7.39	12.51	17.76
Others Liabilities ⓘ	2.78	2.49	3.96	7.74	2.22	3.38	4.54
Total Liabilities ⓘ	16.15	24.33	29.01	48.26	49.06	56.59	71.91
Fixed Assets
Net Fixed Assets ⓘ +	2.48	5.05	6.50	7.13	6.80	12.47	12.24
Gross Block	3.25	6.06	7.79	8.83	8.92	13.08	13.83
Accumulated Depreciation	0.77	1.01	1.28	1.70	2.12	0.60	1.59
CWIP ⓘ	0.04	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0
Inventories	1.71	3.75	5.74	14.96	12.72	15.83	23.24
Trade Receivables	9.66	12.66	11.81	19.80	22.48	25.85	34.95
Cash Equivalents	0.03	0.30	0.04	0.19	0.06	0.44	0.06
Others Assets ⓘ	2.24	2.56	4.93	6.18	6.99	1.99	1.43
Total Assets ⓘ	16.15	24.33	29.01	48.26	49.06	56.59	71.91

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-3	3.21	-5.87	2.32	-9.07	8.41	-3.53
PBT ⓘ	0.42	0.50	0.75	3.80	3.72	3.80	6.13
Adjustment ⓘ	0.80	1.33	1.41	2.44	1.85	1.28	2.07
Changes in Working Capital ⓘ	-4.21	1.47	-7.93	-4.05	-13.64	3.4	-10.71
Tax Paid ⓘ	-0.01	-0.08	-0.09	0.13	-1	-0.07	-1.02
Cash Flow From Investing Activity ⓘ +	-0.61	-2.76	-1.64	-0.71	0.87	-6.09	-0.01
Capex	-0.61	-2.78	-1.72	-1.69	0.24	-6.11	-0.40
Net Investments	0	0	0	0.88	0.62	0	0.38
Others ⓘ	0	0.02	0.08	0.10	0.02	0.03	0.01
Cash Flow From Financing Activity ⓘ +	3.61	-0.19	7.25	-1.46	8.07	-2.35	3.54
Net Proceeds from Shares ⓘ	0.70	0	0.96	1.56	18.17	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0.23	-7.02	-0.41	-0.02
Interest Paid ⓘ	-0.63	-1.10	-1.20	-2.08	-1.42	-0.86	-1.08
Dividend Paid ⓘ	0	0	0	0	0	0	-0.28
Others ⓘ	3.54	0.92	7.49	-1.17	-1.65	-1.07	4.92
Net Cash Flow ⓘ	-0	0.27	-0.26	0.15	-0.13	-0.03	-0

Finance Ratio

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	6.03	6.94	8.85	30.94	12.9	9.73	11.09
ROCE (%)	8.71	11.8	10.32	23.14	15.45	11.53	15.81
Asset Turnover Ratio	1.97	1.49	1.23	0.87	0.88	0.88	1.28
PAT to CFO Conversion(x)	-10	8.92	-10.87	0.83	-3.23	2.55	-0.85
Working Capital Days
Receivable Days	110.90	135	136.20	171.70	180.20	189.50	135.20
Inventory Days	19.60	33	52.80	112.40	118	112	86.90
Payable Days	17.80	70.60	84.50	141.50	116.70	90.90	83.60

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

JFL Life Sciences Ltd FAQs

The current trading price of JFL Life Sciences on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of JFL Life Sciences stood at ₹31.02 Cr

The latest P/E ratio of JFL Life Sciences as of 31-Dec-1969 is 6.43.

The latest P/B ratio of JFL Life Sciences as of 31-Dec-1969 is 0.70.

The 52-week high of JFL Life Sciences is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of JFL Life Sciences is ₹80.06 ( Cr.) .

About JFL Life Sciences Ltd

The Company was incorporated as ‘JFL Life Sciences Private Limited’ on April 25, 2010 as a private limited company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Pursuant to a special resolution of company’s Shareholders passed in the extra-ordinary general meeting held on February 10, 2022, the Company was converted from a private limited company to public limited company and consequently, the name of the Company was changed to ‘JFL Life Sciences Limited’, and a fresh certificate of incorporation dated March 3, 2022 was issued to the Company by the Registrar of Companies, Gujarat at Ahmedabad.

Headquartered in Ahmedabad, Gujarat, JFL Life Sciences is engaged in the business of manufacturing of pharmaceutical products. The company is engaged in domestic as well as international business. With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and a FDA approved state of the art manufacturing facility near Ahmedabad. It is a manufacturing company, so its sales strategy is to sell its products in bulk to pharmaceuticals marketers and traders who in turn provide the channel for sales to customers. It does not sell it under any brand name and it use the same strategy for both domestic & international market. The company exports its products majorly to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing of a particular product. Few of its products are also registered with Ukraine, Uzbekistan, Kazakhstan (CIS countries) through merchants.

Business area of the company

JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS).

Major Events and Milestones

2010: The company was incorporated as a private limited company under the name JFL Life Sciences Private Limited.
2022: The company was converted from a private limited company to a public limited company and its name was changed to JFL Life Sciences Limited.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

JFL Life Sciences Ltd (JFLLIFE) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating